Cited by 135Vaccine Coverage and HesitancyAutism Spectrum Disorder ResearchChild Nutrition and Feeding Issues

Age at first measles-mumps-rubella vaccination in children with autism and school-matched control subjects: a population-based study in metropolitan Atlanta

DeStefano, Frank, Bhasin, Tanya Karapurkar, Thompson, William W., Yeargin-Allsopp, Marshalyn, Boyle, Coleen·2004·PEDIATRICS

Abstract

OBJECTIVE: To compare ages at first measles-mumps-rubella (MMR) vaccination between children with autism and children who did not have autism in the total population and in selected subgroups, including children with regression in development. METHODS: A case-control study was conducted in metropolitan Atlanta. Case children (N = 624) were identified from multiple sources and matched to control children (N = 1824) on age, gender, and school. Vaccination data were abstracted from immunization forms required for school entry. Records of children who were born in Georgia were linked to Georgia birth certificates for information on maternal and birth factors. Conditional logistic regression was used to estimate odds ratios (ORs). RESULTS: The overall distribution of ages at MMR vaccination among children with autism was similar to that of matched control children; most case (70.5%) and control children (67.5%) were vaccinated between 12 and 17 months of age. Similar proportions of case and control children had been vaccinated before 18 or before 24 months. No significant associations for either of these age cutoffs were found for specific case subgroups, including those with evidence of developmental regression. More case (93.4%) than control children (90.6%) were vaccinated before 36 months (OR: 1.49; 95% confidence interval: 1.04-2.14 in the total sample; OR: 1.23; 95% confidence interval: 0.64-2.36 in the birth certificate sample). This association was strongest in the 3- to 5-year age group. CONCLUSIONS: Similar proportions of case and control children were vaccinated by the recommended age or shortly after (ie, before 18 months) and before the age by which atypical development is usually recognized in children with autism (ie, 24 months). Vaccination before 36 months was more common among case children than control children, especially among children 3 to 5 years of age, likely reflecting immunization requirements for enrollment in early intervention programs.

Integrity signals

Registry

Crossref · 10.1542/peds.113.2.259

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • DeStefano 2004 concluded that there was no significant difference between cases and controls in the age at first MMR vaccination up to 18 months (adjusted OR 0.94; 95% CI 0.65 to 1.38).

    “The authors concluded that there was no significant difference between cases and controls in the age at first vaccination up to 18 months (adjusted OR 0.94; 95% CI 0.65 to 1.38)”

    From Vaccines for measles, mumps and rubella in children (2012) · cites this paper as DeStefano 2004

  • DeStefano 2004 concluded that there was no significant difference between cases and controls in the age at first MMR vaccination up to 24 months (adjusted OR 1.01; 95% CI 0.61 to 1.67).

    “and 24 months (adjusted OR 1.01; 95% CI 0.61 to 1.67)”

    From Vaccines for measles, mumps and rubella in children (2012) · cites this paper as DeStefano 2004

Cites

2 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
DeStefano, F., Bhasin, T. K., Thompson, W. W., Yeargin-Allsopp, M., & Boyle, C.
Affiliations
  • Centers for Disease Control and Prevention (US)
  • Battelle (US)
  • National Center on Birth Defects and Developmental Disabilities, CDC, Atlanta, Georgia
Venue
PEDIATRICS
Published
2004-02-01
Volume
113
Issue
2
Pages
259-266
ISSN
  • 0031-4005 (ISSN-L)
  • 1098-4275
OpenAlex
W2169567320
Cited by
135
References
47
Citations by year
2026: 3 · 2025: 4 · 2024: 1 · 2023: 3 · 2022: 3 · 2021: 5 · 2020: 4 · 2019: 4 · 2018: 8 · 2017: 6 · 2016: 7 · 2015: 5 · 2014: 6 · 2013: 8 · 2012: 7
FWCI
11.82
Type
journal article
Language
en
Open access
closed
Locations
  • PEDIATRICS (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Health › Vaccine Coverage and Hesitancy
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Health Sciences › Medicine › Psychiatry and Mental health › Child Nutrition and Feeding Issues
Keywords
MMR vaccine, autism spectrum disorder, age at vaccination, childhood immunization, developmental regression, early intervention programs, school immunization requirements
MeSH terms
Autistic Disorder, Birth Weight, Developmental Disabilities, Child, Preschool, Female, Georgia, Humans, Infant, Male, Intellectual Disability, Population Surveillance, Risk Factors, Vaccination, Odds Ratio, Case-Control Studies, Age Distribution, Measles-Mumps-Rubella Vaccine, Racial Groups

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review